| 1 |
33400617 | Inhibitory effect of resveratrol on the pharmacokinetics of ticagrelor in vivo and in vitro. | 2021 Aug |
2 |
| 2 |
34283374 | A review of the effects of ticagrelor on adenosine concentration and its clinical significance. | 2021 Dec |
1 |
| 3 |
29412111 | Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways. | 2019 |
1 |
| 4 |
29998574 | CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel. | 2019 Feb |
1 |
| 5 |
30580183 | Development of an LC-MS/MS method for simultaneous determination of ticagrelor and its active metabolite during concomitant treatment with atorvastatin. | 2019 Jan 15 |
1 |
| 6 |
28049954 | No Effect of SLCO1B1 and CYP3A4/5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Male Subjects. | 2017 |
1 |
| 7 |
28408884 | Effect of CYP3A4∗1G and CYP3A5∗3 Polymorphisms on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects. | 2017 |
5 |
| 8 |
29167415 | Ticagrelor Leads to Statin-Induced Rhabdomyolysis: A Case Report. | 2017 Nov 23 |
1 |
| 9 |
27563870 | Identification of a New Morpholine Scaffold as a P2Y12 Receptor Antagonist. | 2016 Aug 24 |
1 |
| 10 |
25935875 | Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. | 2015 Aug 1 |
1 |
| 11 |
24477376 | Improved ticagrelor antiplatelet effect on discontinuation of phenytoin. | 2014 May |
2 |
| 12 |
23093043 | Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects. | 2013 Apr |
1 |
| 13 |
23407140 | Exploring the ticagrelor-statin interplay in the PLATO trial. | 2013 |
1 |
| 14 |
23870610 | The effect of ticagrelor on the metabolism of midazolam in healthy volunteers. | 2013 Jul |
1 |